Acceleron Pharma reported $61K in Ordinary Share Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acceleron Pharma XLRN:US $ 0.06M 0M
Akebia Therapeutics AKBA:US $ 0M 0M
Alexion Pharmaceuticals ALXN:US $ 0M 0M
Amgen AMGN:US $ 31877M 71M
Arena Pharmaceuticals ARNA:US $ 0.01M 0M
Bayer BAYN:GR € 2515M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bluebird Bio BLUE:US $ 0.68M 0M
Dicerna Pharmaceuticals DRNA:US $ 0.01M 0M
Eli Lilly And LLY:US $ 598.1M 1.6M
Exelixis EXEL:US $ 0.32M 0M
GlaxoSmithKline GSK:LN 1347M 1M
Karyopharm Therapeutics KPTI:US $ 8K 0
Mirati Therapeutics MRTX:US $ 0.05M 0M
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Novartis NOVN:VX SF 913M 0M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Puma Biotechnology PBYI:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Rigel Pharmaceuticals RIGL:US $ 0.17M 0M
Sangamo Biosciences SGMO:US $ 1.45M 0.01M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
United Therapeutics UTHR:US $ 0.7M 0M
Vertex Pharmaceuticals VRTX:US $ 2.59M 0M